Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PMV Pharmaceuticals, Inc.
Report date June 11, 2021 · Filed June 15, 2021
Jointly reported with Euclidean Capital LLC, Greenland FP LLC, Greenland NFP B Ltd., Greenland NFP LLC, Symmetry Group Ltd., Simons Marilyn, Chhabra Ashvin, SIMONS JAMES H
Section 16 reporting ended · disclosed 2021-06-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 479,062 |
Reported balance
After 2021-06-11 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-06-11 · Sale · Disposed 2,324 · Balance 479,062 F1: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 672,289 |
Reported balance
After 2021-06-11 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-06-11 · Sale · Disposed 3,262 · Balance 672,289 F2: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 728,140 |
Reported balance
After 2021-06-11 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2021-06-11 · Sale · Disposed 3,533 · Balance 728,140 F3: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,521,280 |
Reported balance
After 2021-06-11 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2021-06-11 · Sale · Disposed 12,237 · Balance 2,521,280 F4: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 128,359 |
Reported balance
After 2021-06-11 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2021-06-11 · Sale · Disposed 621 · Balance 128,359 F5: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 474,363 |
Reported balance
After 2021-06-14 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2021-06-14 · Sale · Disposed 4,699 · Balance 474,363 F1: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 665,696 |
Reported balance
After 2021-06-14 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2021-06-14 · Sale · Disposed 6,593 · Balance 665,696 F2: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 720,999 |
Reported balance
After 2021-06-14 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2021-06-14 · Sale · Disposed 7,141 · Balance 720,999 F3: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,496,554 |
Reported balance
After 2021-06-14 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2021-06-14 · Sale · Disposed 24,726 · Balance 2,496,554 F4: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 127,099 |
Reported balance
After 2021-06-14 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2021-06-14 · Sale · Disposed 1,260 · Balance 127,099 F5: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent.
F2: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean.
F3: The shares are held of record by Greenland FP LLC, which is managed by Euclidean.
F4: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean.
F5: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean.
F6: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 1,260 | $34.11 | $42,978.60 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 10 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 127,099 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 24,726 | $34.11 | $843,403.86 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 9 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,496,554 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 7,141 | $34.11 | $243,579.51 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 8 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 720,999 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 6,593 | $34.11 | $224,887.23 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 7 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 665,696 F2 · ownership.nature: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 4,699 | $34.11 | $160,282.89 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 6 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 474,363 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 621 | $33.80 | $20,989.80 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 5 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 128,359 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 12,237 | $33.80 | $413,610.60 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 4 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,521,280 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 3,533 | $33.80 | $119,415.40 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 3 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 728,140 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 3,262 | $33.80 | $110,255.60 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 2 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 672,289 F2 · ownership.nature: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 18:58 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 2,324 | $33.80 | $78,551.20 |
DisclosureSEC source: 0001062993-21-005709 · form4.xml · nonDerivative · entry 1 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 479,062 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 585 | $32.68 | $19,117.80 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 10 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 129,980 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 11,485 | $32.68 | $375,329.80 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 9 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,533,517 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 3,317 | $32.68 | $108,399.56 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 8 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 731,673 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 3,063 | $32.68 | $100,098.84 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 7 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 675,551 F2 · ownership.nature: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 2,183 | $32.68 | $71,340.44 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 6 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 481,386 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 1,121 | $33.64 | $37,710.44 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 5 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 129,565 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 22,070 | $33.64 | $742,434.80 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 4 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,545,002 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 6,372 | $33.64 | $214,354.08 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 3 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 734,990 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 5,883 | $33.64 | $197,904.12 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 2 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 678,614 F2 · ownership.nature: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 17:35 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 4,192 | $33.64 | $141,018.88 |
DisclosureSEC source: 0001062993-21-005572 · form4.xml · nonDerivative · entry 1 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 483,569 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 896 | $33.38 | $29,908.48 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 10 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 130,686 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 17,664 | $33.38 | $589,624.32 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 9 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,567,072 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 5,101 | $33.38 | $170,271.38 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 8 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 741,362 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 4,708 | $33.38 | $157,153.04 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 7 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 684,497 F2 · ownership.nature: 2. The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 3,355 | $33.38 | $111,989.90 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 6 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 487,761 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 1,019 | $33.62 | $34,258.78 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 5 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 131,582 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 16,901 | $33.62 | $568,211.62 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 4 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,584,736 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 4,946 | $33.62 | $166,284.52 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 3 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 746,463 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 4,564 | $33.62 | $153,441.68 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 2 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 689,205 F2 · ownership.nature: 2. The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | SaleCommon Stock | 3,291 | $33.62 | $110,643.42 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 1 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 491,116 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionSeries C Preferred Stock · Derivative | 132,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · derivative · entry 8 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 132,601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.exercise_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.expiration_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. F6 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionSeries C Preferred Stock · Derivative | 751,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · derivative · entry 7 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 751,409 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.exercise_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.expiration_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. F5 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionSeries B Preferred Stock · Derivative | 2,601,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · derivative · entry 6 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,601,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.exercise_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.expiration_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionSeries B Preferred Stock · Derivative | 693,769 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · derivative · entry 5 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 693,769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.exercise_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F1 · derivative.expiration_date: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F2 · ownership.nature: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionCommon Stock | 132,601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · nonDerivative · entry 4 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 132,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. F6 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionCommon Stock | 751,409 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · nonDerivative · entry 3 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 751,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. F5 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionCommon Stock | 2,601,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · nonDerivative · entry 2 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,601,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. Read SEC document |
| September 29, 2020 Filed Sep 29, 2020 16:47 UTC | PMV Pharmaceuticals, Inc. PMVP · Entity 7062 | ConversionCommon Stock | 693,769 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-052350 · doc4.xml · nonDerivative · entry 1 Euclidean Capital LLC · CIK 0001825034 · Former 10% Owner Greenland A LLC · CIK 0001825026 · Former 10% Owner Greenland FP LLC · CIK 0001825227 · Former 10% Owner Greenland NFP B Ltd. · CIK 0001825238 · Former 10% Owner Greenland NFP LLC · CIK 0001825241 · Former 10% Owner Simons Marilyn · CIK 0001825290 · Former 10% Owner Chhabra Ashvin · CIK 0001825293 · Former 10% Owner SIMONS JAMES H · CIK 0000941976 · Former 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 693,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of each of the Series B Preferred Stock and Series C Preferred Stock are convertible, and shall automatically convert into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and have no expiration date. F2 · ownership.nature: The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Marilyn Simons and James Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F3 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 3, except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.